PMV Pharmaceuticals (PMVP) Common Equity (2019 - 2026)
PMV Pharmaceuticals (PMVP) posted Common Equity of $71.5 million for Q2 2026, down 49.1% from $140.61 million a year earlier and down 18.7% from the prior quarter.
Powered by 
Analysis
PMV Pharmaceuticals (PMVP) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, PMV Pharmaceuticals' Common Equity came in at $104.71 million, down 40.5% from FY2024.
- Annual Common Equity has declined for five consecutive years, with a five-year compound annual growth rate of -21.8% (FY2020 to FY2025).
- In prior years, PMV Pharmaceuticals' Common Equity was $176.08 million in FY2024 (-22.0%), $225.69 million in FY2023 (-8.3%), $246.03 million in FY2022 (-20.3%) and $308.56 million in FY2021 (-14.1%).
- The Q2 2026 figure stands as the lowest quarterly Common Equity since Q2 2020.
- On a year-over-year basis, Common Equity has declined in each of the last 20 quarters, with an average decline of 33.9% over the last eight quarters.
- Over the past five years, the year-over-year decline in Common Equity ranged from 1.6% (Q2 2024) to 49.1% (Q2 2026).
- According to Business Quant data, Common Equity for the three prior quarters was $87.97 million (Q1 2026), $104.71 million (Q4 2025) and $121 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | PMV Pharmaceuticals | 72.71 Mn | -342.47 Mn | - | 71.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71.50 Mn |
| Mar 31, 2026 | 87.97 Mn |
| Dec 31, 2025 | 104.71 Mn |
| Sep 30, 2025 | 121.00 Mn |
| Jun 30, 2025 | 140.61 Mn |
| Mar 31, 2025 | 160.11 Mn |
| Dec 31, 2024 | 176.08 Mn |
| Sep 30, 2024 | 197.91 Mn |
| Jun 30, 2024 | 214.32 Mn |
| Mar 31, 2024 | 212.68 Mn |
| Dec 31, 2023 | 225.69 Mn |
| Sep 30, 2023 | 237.61 Mn |
| Jun 30, 2023 | 217.81 Mn |
| Mar 31, 2023 | 230.17 Mn |
| Dec 31, 2022 | 246.03 Mn |
| Sep 30, 2022 | 261.19 Mn |
| Jun 30, 2022 | 276.97 Mn |
| Mar 31, 2022 | 291.84 Mn |
| Dec 31, 2021 | 308.56 Mn |
| Sep 30, 2021 | 324.95 Mn |
API Access
PMV Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PMVP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PMVP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PMVP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();